Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
European Journal of Clinical Investigation
|
August 1, 1989
Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit
P Henriksson, M Stamberger, M Eriksson, et al.
Lancet (London, England)
|
November 18, 1989
Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate
P Henriksson, M Eriksson, S Ericsson, et al.
Der Urologe. Ausg. A
|
September 1, 1995
[Intramuscular depot estrogens (Estradurin) in treatment of patients with prostate carcinoma. Historical aspects, mechanism of action, results and current clinical status]
R Stege, K Carlström, P O Hedlund, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1996
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males
L Berglund, K Carlström, R Stege, et al.
Microvascular Research
|
October 21, 1999
A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette
J Zhang, X Ying, Q Lu, et al.
The Journal of Clinical Investigation
|
April 1, 1993
Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits
A Freyschuss, A Stiko-Rahm, J Swedenborg, et al.
Biochimica Et Biophysica Acta
|
January 12, 2002
On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions
A Freyschuss, A Al-Schurbaji, I Björkhem, et al.
The Prostate
|
January 1, 1989
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
K Carlström, L Collste, A Eriksson, et al.
The Prostate
|
January 1, 1989
Single-drug parenteral estrogen treatment in prostatic cancer: a study of two maintenance-dose regimens
R Stege, K Carlström, L Collste, et al.
The Prostate
|
January 1, 1989
Estrogen therapy and liver function--metabolic effects of oral and parenteral administration
B von Schoultz, K Carlström, L Collste, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
European Journal of Clinical Investigation
|
August 1, 1989
Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit
P Henriksson, M Stamberger, M Eriksson, et al.
Lancet (London, England)
|
November 18, 1989
Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate
P Henriksson, M Eriksson, S Ericsson, et al.
Der Urologe. Ausg. A
|
September 1, 1995
[Intramuscular depot estrogens (Estradurin) in treatment of patients with prostate carcinoma. Historical aspects, mechanism of action, results and current clinical status]
R Stege, K Carlström, P O Hedlund, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1996
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males
L Berglund, K Carlström, R Stege, et al.
Microvascular Research
|
October 21, 1999
A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette
J Zhang, X Ying, Q Lu, et al.
The Journal of Clinical Investigation
|
April 1, 1993
Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits
A Freyschuss, A Stiko-Rahm, J Swedenborg, et al.
Biochimica Et Biophysica Acta
|
January 12, 2002
On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions
A Freyschuss, A Al-Schurbaji, I Björkhem, et al.
The Prostate
|
January 1, 1989
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
K Carlström, L Collste, A Eriksson, et al.
The Prostate
|
January 1, 1989
Single-drug parenteral estrogen treatment in prostatic cancer: a study of two maintenance-dose regimens
R Stege, K Carlström, L Collste, et al.
The Prostate
|
January 1, 1989
Estrogen therapy and liver function--metabolic effects of oral and parenteral administration
B von Schoultz, K Carlström, L Collste, et al.
Page
of 14